Gunderson Dettmer has advised Osanni Bio. Ropes & Gray has advised Patient Square Capital. Osanni Bio, a development-stage therapeutics platform, has completed a $190 million Series...
Osanni Bio Secures $190 Million in Series B Financing Led by Patient Square Capital
Shionogi Acquires Global Rights to RADICAVA Business from Tanabe Pharma Corporation for $2.5 Billion
Cleary Gottlieb Steen & Hamilton LLP has advised Shionogi & Co. Ltd. and Shionogi Inc.; Ropes & Gray LLP has advised Tanabe Pharma Corporation. Shionogi &...
Bristol Myers Squibb and Bain Capital Establish Biopharmaceutical Company Focused on Immunology Therapies
Ropes & Gray has advised Bain Capital on the deal. Bristol Myers Squibb and Bain Capital have announced the creation of a new independent biopharmaceutical company...
Sanofi Invests up to $25 Million in Adagene SAFEbody Antibody Program
Ropes & Gray has advised Sanofi. Davis Polk & Wardwell and Walkers (Hong Kong) have advised Adagene Inc. Sanofi has announced a strategic investment of up...
Kailera Therapeutics’ $400 Million Series A Financing
Ropes & Gray advised Kailera Therapeutics, Inc. on the transaction. Kailera Therapeutics, Inc. (“Kailera”) announced raising $400 million in Series A financing. Kailera announced its launch...
Serán Bioscience’s $200 Million Growth Transaction
Ropes & Gray represented Bain Capital Life Sciences in the transaction. Serán Bioscience (“Serán”), a leading contract development and manufacturing organization (CDMO), announced a strategic growth...
Bicara Therapeutics’ $315 Million IPO
Goodwin Procter advised Bicara Therapeutics on the offering, and Ropes & Gray advised the underwriters. Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company, announced the...
Chiesi Group’s Collaboration with Gossamer Bio
Ropes & Gray advised Chiesi Group on the transaction, and Latham & Watkins advised Gossamer Bio. Chiesi Group announced it has entered into a global collaboration...
Rhythm Pharmaceuticals’ $150 Million Financing
Latham & Watkins is advising Rhythm Pharmaceuticals on the transaction, and Ropes & Gray is advising Perceptive Advisors LLC. Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (Rhythm), a commercial-stage...